MedTrace Logo

Improved Efficacy of Selective Laser Trabeculoplasty With the Addition of Rocklatan Post-treatment vs Artificial Tears Post-treatment

NCT06819046 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2026-03-18

No results posted yet for this study

Summary

A randomized, single-site, parallel-group, prospective study of patients who are candidates for SLT, to study the effect of IOP change with Rocklatan vs artificial tears.

Conditions

Interventions

DRUG

Rocklatan

netarsudil and latanoprost ophthalmic solution 0.02%/0.005%

DRUG

Systane Ultra

artificial tears

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • Colorado Ophthalmology Associates PC

    lead OTHER

Principal Investigators

  • Kingsley Okafor, MD · Colorado Ophthalmology Associates PC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-14
Primary Completion
2025-12-17
Completion
2025-12-17
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06819046 on ClinicalTrials.gov